Nordic Nanovector is a Norway-based biopharmaceutical company that researches and develops radioimmunotherapies for the treatment of hematological cancers.
Business Model:
Revenue: $369.6k
Employees: 11-50
Address: Kjelsasveien 168 B
City: Oslo
State: oslo
Zip: 0884
Country: NO
Nordic Nanovector is a Norway-based biopharmaceutical company that researches and develops radioimmunotherapies for the treatment of hematological cancers.
Contact Phone:
Contact Email:
Listed Exchange:
OSL
IPO Date:
3/27/2015
Ticker Symbol:
NANO
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2019 | Grant | $0 |
Norwegian Research Council Norwegian Research Council |
1/2022 | Post-IPO Equity | $28.5M | 12/2019 | Grant | $1.3M | 1/2010 | Seed Round | - |
Birk Venture Birk Venture |
10/2019 | Private Placement | $26.4M | 2/2019 | Private Placement | $4M | 3/2019 | Private Placement | $361.3k | 3/2022 | Post-IPO Equity | $88.4k | 9/2020 | Private Placement | $24.5M | 12/2019 | Grant | 1 | $1.3M |
Norwegian Research Council Norwegian Research Council Norwegian Research Council Norwegian Research Council |
1/2010 | Seed Round | 1 | - |
Birk Venture Birk Venture |
---|
Announced Date | Name | Price |
---|---|---|
11/2022 | APIM Therapeutics |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|